Ameriprise’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $135K | Sell |
|
|||||
|
2023
Q3 | $4.06M | Sell |
|
|||||
|
2023
Q2 | $5.18M | Buy |
|
|||||
|
2023
Q1 | $5.61M | Sell |
|
|||||
|
2022
Q4 | $5.94M | Sell |
|
|||||
|
2022
Q3 | $5.59M | Sell |
|
|||||
|
2022
Q2 | $11.2M | Sell |
|
|||||
|
2022
Q1 | $13.1M | Sell |
|
|||||
|
2021
Q4 | $13.6M | Buy |
|
|||||
|
2021
Q3 | $8.84M | Buy |
|
|||||
|
2021
Q2 | $6.46M | Buy |
|
|||||
|
2021
Q1 | $5.04M | Buy |
|
|||||
|
2020
Q4 | $5.08M | Buy |
|
|||||
|
2020
Q3 | $4.51M | Buy |
|
|||||
|
2020
Q2 | $4.11M | Sell |
|
|||||
|
2020
Q1 | $3.95M | Sell |
|
|||||
|
2019
Q4 | $5.17M | Sell |
|
|||||
|
2019
Q3 | $4.94M | Sell |
|
|||||
|
2019
Q2 | $5.29M | Buy |
|
|||||
|
2019
Q1 | $2.94M | Sell |
|
|||||
|
2018
Q4 | $2.53M | Sell |
|
|||||
|
2018
Q3 | $4.43M | Buy |
|
|||||
|
2018
Q2 | $3.56M | Sell |
|
|||||
|
2018
Q1 | $6.6M | Buy |
|
|||||
|
2017
Q4 | $6.64M | Sell |
|
|||||
|
2017
Q3 | $8.27M | Buy |
|
|||||
|
2017
Q2 | $10.5M | Buy |
|
|||||
|
2017
Q1 | $9.52M | Sell |
|
|||||
|
2016
Q4 | $9.49M | Buy |
|
|||||
|
2016
Q3 | $7.63M | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $2.29M | Buy |
|
|||||
|
2015
Q3 | $1.8M | Buy |
|
|||||
|
2015
Q2 | $1.54M | Buy |
|
|||||
|
2015
Q1 | $781K | Buy |
|